Kymera Therapeutics patents new STAT6 inhibitors

ScienceLaser-boosted microscopes could reveal new drug targets, sharpen views inside cells

ScienceThe ocean current that warms Europe may be more resilient than feared

FierceBiotechAI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data finds

Clinical OMICsRemote Monitoring Benefits Unclear After Hospitalization for Serious Infection

FierceBiotechNovo reports data breach, tells clinical trial patients to 'remain vigilant'

Endpoints NewsThe seeming inevitability of rising healthcare costs

FierceBiotechPredicta links with Spanish university to offer diagnostic for blood cancers

BioPharma DiveSummit pulls $500M share sale a day after announcing it

Endpoints NewsDrugmakers are turning to logistics providers as trade disruptions linger, DHL exec says

BioPharma DiveSensorion, citing Regeneron competition, shifts focus to a different hearing loss therapy

Endpoints NewsSummit withdraws $500M offering, citing 'market conditions'

BioWorldScore in phase I CML trial has Enliven looking ahead to phase III